BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10159647)

  • 1. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
    Anadaleeb SS; Tallman RF
    Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician attitudes toward pharmaceutical sales representatives.
    Andaleeb SS; Tallman RF
    Health Care Manage Rev; 1995; 20(3):68-76. PubMed ID: 7591754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians.
    Spiller LD; Wymer WW
    Health Mark Q; 2001; 19(1):91-106. PubMed ID: 11727295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
    Barton L
    J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family doctors' views of pharmaceutical sales representatives: assessment scale development.
    Kersnik J; Klemenc-Ketis Z; Petek-Ster M; Tusek-Bunc K; Poplas-Susic T; Kolsek M
    Fam Pract; 2011 Aug; 28(4):456-60. PubMed ID: 21292626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry.
    Hyman PL; Hochman ME; Shaw JG; Steinman MA
    Acad Med; 2007 Jan; 82(1):94-9. PubMed ID: 17198299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.
    Sarikaya O; Civaner M; Vatansever K
    Adv Health Sci Educ Theory Pract; 2009 Dec; 14(5):713-24. PubMed ID: 19184498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical drug marketing strategies and tactics: a comparative analysis of attitudes held by pharmaceutical representatives and physicians.
    Parker RS; Pettijohn CE
    Health Mark Q; 2005; 22(4):27-43. PubMed ID: 16597582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].
    Ben Abdelaziz A; Harrabi I; Rahmani S; Ghedira A; Gaha K; Ghannem H
    East Mediterr Health J; 2003; 9(5-6):1075-83. PubMed ID: 16450540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician preferences and attitudes regarding industry support of CME programs.
    Mueller PS; Hook CC; Litin SC
    Am J Med; 2007 Mar; 120(3):281-5. PubMed ID: 17349454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.